E-LIB Suche - Ergebnisse für: Castelo-Branco, L

1

Real-world evidence reported for clinical efficacy evaluati..:

Derksen, J.W.G. ; Martins-Branco, D. ; Valachis, A....
ESMO Real World Data and Digital Oncology. 4 (2024) - p. 100039 , 2024

Link: https://doi.org/10.1016/..

2

ESMO Guidance for Reporting Oncology real-World evidence (G..:

Castelo-Branco, L. ; Pellat, A. ; Martins-Branco, D....
ESMO Real World Data and Digital Oncology. 1 (2023) - p. 100003 , 2023

Link: https://doi.org/10.1016/..

3

Treatment patterns in a population of 1.4 million individua..:

Coca, A ; Borghi, C ; Stergiou, G S...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

COVID-19 in cancer patients: update from the joint analysis..:

Martin, P. ; Tsourti, Z. ; Ribeiro, J....
ESMO Open. 8 (2023) 3 - p. 101566 , 2023

Link: https://doi.org/10.1016/..

5

Challenges and knowledge gaps with immune checkpoint inhibi..:

Castelo-Branco, L. ; Morgan, G. ; Prelaj, A....
ESMO Open. 8 (2023) 1 - p. 100764 , 2023

Link: https://doi.org/10.1016/..

6

Learning lessons from the COVID-19 pandemic for real-world ..:

Castelo-Branco, L. ; Lee, R. ; Brandão, M....
ESMO Open. 8 (2023) 4 - p. 101596 , 2023

Link: https://doi.org/10.1016/..

7

Living in endemic area for infectious diseases accelerates ..:

Durso, D.F. ; Silveira-Nunes, G. ; Coelho, M.M....
Mechanisms of Ageing and Development. 207 (2022) - p. 111713 , 2022

Link: https://doi.org/10.1016/..

8

237P Immune checkpoint inhibitor therapy and outcomes from ..:

Cortellini, A. ; Dettorre, G. ; Dafni, U....
Immuno-Oncology and Technology. 16 (2022) - p. 100226 , 2022

Link: https://doi.org/10.1016/..

9

COVID-19 in patients with cancer: first report of the ESMO ..:

Castelo-Branco, L. ; Tsourti, Z. ; Gennatas, S....
ESMO Open. 7 (2022) 3 - p. 100499 , 2022

Link: https://doi.org/10.1016/..

10

Beyond the lessons learned from the COVID-19 pandemic: oppo..:

Castelo-Branco, L. ; Awada, A. ; Pentheroudakis, G....
ESMO Open. 6 (2021) 5 - p. 100237 , 2021

Link: https://doi.org/10.1016/..

11

PCV28 CHARACTERIZATION OF COSTS AND PATIENTS WITH INCIDENT ..:

Boman, K. ; Lindmark, K. ; Olofsson, M....
Value in Health. 22 (2019) - p. S546 , 2019

Link: https://doi.org/10.1016/..

12

PCV48 - TOTAL ANNUAL HEALTHCARE COSTS OF HEART FAILURE BETW..:

Boman, K. ; Lindmark, K. ; Stålhammar, J....
Value in Health. 21 (2018) - p. S100 , 2018

Link: https://doi.org/10.1016/..

13

Cost-Effectiveness of Aflibercept in the Treatment of Macul..:

Eriksson, M. ; Castelo-Branco, A. ; Nilsson, J.
Value in Health. 17 (2014) 7 - p. A608 , 2014

Link: https://doi.org/10.1016/..

14

Left atrium wall metabolism by PET-CT in patients with hype..:

Alves, P ; Fernandes, C R ; Silva, R...
European Heart Journal - Cardiovascular Imaging. 25 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

15

Predicting conversion from mild cognitive impairment to Alz..:

Agostinho, Daniel ; Simões, Marco ; Castelo-Branco, Miguel
Brain Communications. 6 (2024) 4 - p. , 2024

Link: https://doi.org/10.1093/..